Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 28
2007 30
2008 25
2009 17
2010 16
2011 13
2012 35
2013 32
2014 20
2015 35
2016 28
2017 22
2018 15
2019 22
2020 44
2021 91
2022 53
Text availability
Article attribute
Article type
Publication date

Search Results

399 results
Results by year
Filters applied: . Clear all
Page 1
Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis.
Wenzel M, Nocera L, Collà Ruvolo C, Würnschimmel C, Tian Z, Shariat SF, Saad F, Tilki D, Graefen M, Kluth LA, Briganti A, Mandel P, Montorsi F, Chun FKH, Karakiewicz PI. Wenzel M, et al. Among authors: chun fkh. Prostate Cancer Prostatic Dis. 2022 Feb;25(2):139-148. doi: 10.1038/s41391-021-00395-4. Epub 2021 May 30. Prostate Cancer Prostatic Dis. 2022. PMID: 34054128 Free PMC article. Review.
Reply by Authors.
Wenzel M, Nocera L, Collà Ruvolo C, Würnschimmel C, Tian Z, Shariat SF, Saad F, Briganti A, Tilki D, Graefen M, Kluth LA, Mandel P, Chun FKH, Karakiewicz PI. Wenzel M, et al. Among authors: chun fkh. J Urol. 2021 Jul;206(1):79. doi: 10.1097/JU.0000000000001695.03. Epub 2021 Apr 6. J Urol. 2021. PMID: 33820427 No abstract available.
Reply by Authors.
Baunacke M, Schmidt ML, Groeben C, Borkowetz A, Thomas C, Koch R, Chun FKH, Ihrig A, Weissbach L, Huber J. Baunacke M, et al. Among authors: chun fkh. J Urol. 2020 Mar;203(3):560-561. doi: 10.1097/JU.0000000000000541.03. Epub 2019 Dec 3. J Urol. 2020. PMID: 31794360 No abstract available.
Prostatakarzinom--pN1: Sind wirklich alle Patienten gleich?
Kluth LA, Chun FK. Kluth LA, et al. Among authors: chun fk. Aktuelle Urol. 2016 Apr;47(2):113-5. doi: 10.1055/s-0042-106005. Epub 2016 Apr 14. Aktuelle Urol. 2016. PMID: 27078133 German. No abstract available.
Overall Survival After Systemic Treatment in High-volume Versus Low-volume Metastatic Hormone-sensitive Prostate Cancer: Systematic Review and Network Meta-analysis.
Wenzel M, Würnschimmel C, Nocera L, Collà Ruvolo C, Tian Z, Shariat SF, Saad F, Briganti A, Tilki D, Graefen M, Kluth LA, Roos FC, Mandel P, Chun FKH, Karakiewicz PI. Wenzel M, et al. Among authors: chun fkh. Eur Urol Focus. 2022 Mar;8(2):399-408. doi: 10.1016/j.euf.2021.04.003. Epub 2021 Apr 11. Eur Urol Focus. 2022. PMID: 33853754 Review.
399 results